In 2019, the Biomedical Advanced Research and Development Authority (BARDA) expanded their Division of Research, Innovation, and Ventures (DRIVe) to stimulate investment and innovation in health security products and technologies. DRIVe provides technical and financial resources to entrepreneurs whose ideas have the potential to transform emergency preparedness, detection, and response.
Life Science Washington Institute has been selected as one of 13 sites in the DRIVe accelerator network to identify inventors and connect them with resources that will enable earlier treatment and warning for communities against outbreaks.
To date, 54 BARDA-supported products have achieved regulatory approval, licensure or clearance. BARDA DRIVe brings together the best ideas from the medical and scientific communities, together with government and venture capital investment, to drive innovation that will strengthen our nation’s health security. To learn more about preparing for and responding to public health emergencies, visit the HHS public health emergency website, www.phe.gov. For more information on partnering with BARDA on developing medical countermeasures, visit www.medicalcountermeasures.gov, and for more on DRIVe, visit drive.hhs.gov. |